LEGAL PROTECTION FOR VACCINE RECIPIENT CONSUMERS: PERCEPTIONS OF HEALTH AND NON-HEALTH WORKERS AFTER THE COVID-19 VACCINATION

Main Article Content

DHANISWARA K. HARJONO, AGO HARLIM, HULMAN PANJAITAN, WILSON RAJAGUKGUK, LAMHOT NAIBAHO

Abstract

The goal of Covid-19 vaccination is to decrease the spread of the virus, lower the severity and death rate caused by Covid-19, attain collective immunity within the community, and safeguard individuals from Covid-19 so that they can continue to be socially and economically productive. The research method employed is normative juridical research in conjunction with empirical research in the form of quantitative research using a survey design. Covid-19 vaccine access accelerates pandemic response. Regarding disarmament implementation, several things have happened in the field, including a) the procedure for implementing disarmament has not fully followed the health protocol, b) the procedure for withdrawing vaccination has not been carried out properly, c) there has not been a thorough socialization of vaccines to recipients. Thus research on Importance of legal protection for Indonesian vaccine recipients because of the legal protection of consumer rights.

Article Details

Section
Public Law
Author Biography

DHANISWARA K. HARJONO, AGO HARLIM, HULMAN PANJAITAN, WILSON RAJAGUKGUK, LAMHOT NAIBAHO

DHANISWARA K. HARJONO 1*, AGO HARLIM 2, HULMAN PANJAITAN 3, WILSON RAJAGUKGUK 4, LAMHOT NAIBAHO 4
Universitas Kristen Indonesia, Indonesia 1

References

Larsen, G., & Lawson, R. (2013). Consumer rights: An assessment of justice. Journal of businessethics, 112(3), 515-528.

Devenney, J., & Kenny, M. (Eds.). (2012). European consumer protection: theory and practice. CambridgeUniversity Press.

Schrader, U. (2007). The moral responsibility of consumers as citizens. International Journal of Innovationand Sustainable Development, 2(1), 79-96.

Bárd, P., Carrera, S., Guild, E., & Kochenov, D. (2016). An EU mechanism on democracy, the rule of lawand fundamental rights. CEPS Paper in Liberty and Security in Europe.

LeBlanc, C. (2018). Land of the Free Market: US Companies Continue to Enjoy Greater Legal Protectionthan Consumers. Suffolk J. Trial & App. Advoc., 24, 94.

Aziz, M., Ghofur, A., & Hidayati, N. N. (2021). Regulation on the Implementation of Halal ProductAssurance in Indonesia: Statute Approaches Study. Ulul Albab: Jurnal Studi dan Penelitian HukumIslam, 4(2), 209-230.

Bartley, T. (2018). Rules without rights: Land, labor, and private authority in the global economy. OxfordUniversity Press.

Chandra, T. (2019). Non-Litigation Process Land Dispute Settlement for Legal Certainty. SubstantiveJustice International Journal of Law, 2(2), 177-194.

Wantu, F. M., & Sarson, M. T. Z. (2020). Legal Protection of Women as Victim of DomesticViolence. Indonesian Journal of Advocacy and Legal Services, 1(2), 243-258.

Dinanti, D., Sakti, M., Irfani, I. P., & Pramita, S. A. (2020). Politics of Law for the Protection of Debtorsas Consumers in Fintech based Loaning Services. Unnes Law Journal: Jurnal Hukum Universitas NegeriSemarang, 6(2), 427-444.

Hedegaard, J. S., & Wrbka, S. (2016). The notion of consumer under EU legislation and EU case law:Between the poles of legal certainty and flexibility. In Legal Certainty in a Contemporary Context (pp.69-88). Springer, Singapore.

Pager, S. (2003). Strictness vs. Discretion: The European Court of Justice's Variable Vision of GenderEquality. The American Journal of Comparative Law, 51(3), 553-610.

Shin, M. D., Shukla, S., Chung, Y. H., Beiss, V., Chan, S. K., Ortega-Rivera, O. A., ... & Steinmetz, N. F.(2020). COVID-19 vaccine development and a potential nanomaterial path forward. Naturenanotechnology, 15(8), 646-655.

Foged, C. (2011). Subunit vaccines of the future: the need for safe, customized and optimized particulatedelivery systems. Therapeutic delivery, 2(8), 1057-1077.

Vetter, V., Denizer, G., Friedland, L. R., Krishnan, J., & Shapiro, M. (2018). Understanding modern-dayvaccines: what you need to know. Annals of medicine, 50(2), 110-120.

Doytchinova, I. A., & Flower, D. R. (2007). VaxiJen: a server for prediction of protective antigens, tumourantigens and subunit vaccines. BMC bioinformatics, 8(1), 1-7.

Andreadakis, Z., Kumar, A., Román, R. G., Tollefsen, S., Saville, M., & Mayhew, S. (2020). The COVID-19vaccine development landscape. Nature reviews. Drug discovery, 19(5), 305-306.

Malik, A. A., McFadden, S. M., Elharake, J., & Omer, S. B. (2020). Determinants of COVID-19 vaccineacceptance in the US. EClinicalMedicine, 26, 100495.

Jeyanathan, M., Afkhami, S., Smaill, F., Miller, M. S., Lichty, B. D., & Xing, Z. (2020). Immunologicalconsiderations for COVID-19 vaccine strategies. Nature Reviews Immunology, 20(10), 615-632.

Samuel, R. Flu Shot Season, COVID-19 and How Pharmacies are Bracing for Impact.

Kłoskowicz, M., & Kasperkiewicz, K. (2020). Człowiek kontra wirusy. No Limits, (2), 28-29.

Peeples, L. (2020). News Feature: Avoiding pitfalls in the pursuit of a COVID-19 vaccine. Proceedings ofthe National Academy of Sciences, 117(15), 8218-8221.

Iboi, E. A., Ngonghala, C. N., & Gumel, A. B. (2020). Will an imperfect vaccine curtail the COVID-19pandemic in the US?. Infectious Disease Modelling, 5, 510-524.

Kalla, I. S., & Laher, A. (2020). COVID-19: the concept of herd immunity–is it a strategy for SouthAfrica?. Wits Journal of Clinical Medicine, 2(Si1), 39-42.

Riad, A., Schünemann, H., Attia, S., Peričić, T. P., Žuljević, M. F., Jürisson, M., ... & Klugar, M. (2021).COVID-19 Vaccines Safety Tracking (CoVaST): Protocol of a Multi-Center Prospective Cohort Study for

RUSSIAN LAW JOURNAL Volume XI (2023) Issue 6s

Active Surveillance of COVID-19 Vaccines’ Side Effects. International journal of environmental research and public health, 18(15), 7859.

Pangarsa, E. A., Setiawan, B., Santosa, S., Naibaho, R. M., Rizky, D., Suyono, S., ... & Suharti, C. (2021).COVID-19 vaccination in patients with cancer: Position paper from the Indonesian Society of Hematologyand Medical Oncology (ISHMO) of Semarang. Bali Medical Journal, 10(1).

Mazzoni, A., Di Lauria, N., Maggi, L., Salvati, L., Vanni, A., Capone, M., ... & Annunziato, F. (2021). First-dose mRNA vaccination is sufficient to reactivate immunological memory to SARS-CoV-2 in recoveredCOVID-19 subjects. The Journal of Clinical Investigation.

Tuite, A. R., Zhu, L., Fisman, D. N., & Salomon, J. A. (2021). Alternative dose allocation strategies toincrease benefits from constrained COVID-19 vaccine supply. Annals of internal medicine, 174(4), 570-572.

Zuin, M., Rigatelli, G., Zuliani, G., Rigatelli, A., Mazza, A., & Roncon, L. (2020). Arterial hypertensionand risk of death in patients with COVID-19 infection: systematic review and meta-analysis. The Journalof infection, 81(1), e84.

Abi Jaoude, J., Kouzy, R., El Alam, M. B., Subbiah, V., Taniguchi, C. M., Ludmir, E. B., & Lin, T. A. (2020,October). Exclusion of Older Adults in COVID-19 Clinical Trials. In Mayo Clinic Proceedings (Vol. 95, No.10, p. 2293). Elsevier.

Price, D. N., Kunda, N. K., McBride, A. A., & Muttil, P. (2016). Vaccine preparation: past, present, andfuture. Delivery Systems for Tuberculosis Prevention and Treatment, 69.

Petousis-Harris, H. (2020). Assessing the safety of COVID-19 vaccines: a primer. Drug safety, 43(12), 1205-1210.

Scarabel, L., Guardascione, M., Dal Bo, M., & Toffoli, G. (2021). Pharmacological strategies to preventSARS-CoV-2 infection and to treat the early phases of COVID-19 disease. International Journal of InfectiousDiseases.

Sumas, S. (2021). New Normal Workplace during the Covid-19 Pandemic in Indonesia. Jurnal BinaKetenagakerjaan, 2(1), 25-41.

Mackenzie, G. A., Osei, I., Salaudeen, R., Secka, O., D’Alessandro, U., Clarke, E., ... & Mulholland, K.(2021). Pneumococcal Conjugate Vaccination Schedules Acquisition, Immunogenicity and PneumococcalConjugate and Yellow Fever Vaccine Co-Administration Study.

Sudikno Mertokusumo, (1984), Bunga Rampai Ilmu Hukum, Yogyakarta : Liberty.

Philipus M. Hardjono, (1987), Perlindungan Hukum Bagi Rakyat Indoensia, Surabaya : PT. Bina Ilmu.

Hulman Panjaitan, (2021), Hukum Perlidungan Konsumen, Jakarta : Kencana.

Rafael La Porta, Journal of Financial Economics No. 58, Oktober 1999.

Buku Ajar Imunisasi, Kementerian Kesehatan RI, GAVI The Vaccine Alliance. 2014. Konsep Dasar Imunisasi.

Hilbe, J.M., (2015 ) Practical Guide to Logistic Regression, Taylor & Francis.

Hosmer, D.W. dan Stanley Lemeshow, Rodney X. Sturdivant, ( 2013) Applied Ligistic Regression, Wiley.

Garson, G.D., (2016),Logistic Regression: Binary & Multinomial: 2016 Edition (Statistical Associates "BlueBook" Series Book 2) Kindle Edition

WHO.2020. Vaccines and immunization : what is vaccination.

CDC. 2020. Understanding How COVID-19 Vaccines Work. Centers for Disease Control andPrevention.Available on: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/how-theywork.html#:~:text=Once%20vaccinated%2C%20our%20immune%20system,recognize%20and%20fight%20the%20virus.

Komite Penanganan Covid-19 dan Pemulihan Ekonomi Nasional. Paket Advokasi Vaksin Covid-19 LindungiDiri, Lindungi Negeri. Kementrian Kesehatan Republik Indonesia, 2020.

Kementerian Kesehatan RI. 2020. Seputar Pelaksanaan VaksinasiCOVID-19. https://kesmas.kemkes.go.id/assets/uploads/contents/others/FAQ_VAKSINASI_COVID__call_center.pdf

PAPDI. Rekomendasi PAPDI tentang Vaksinasi COVID-19. 18 Januari 2021. Perhimpunan Dokter SpesialisPenyakit Dalam Indonesia. https://www.papdi.or.id/berita/info-papdi/998-rekomendasi-papdi-tentang-pemberian-vaksinasi-covid-19

Kuntoro Harimurti. Penapisan untuk Vaksinasi COVID-19. 13 Februari 2021. Kementerian KesehatanRepublik Indonesia. https://persi.or.id/wp-content/uploads/2021/02/paparan-kuntjoro-harimurti-130221.pdf